Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal CancerTakashi Kojima, Éric François, Antoine Adenis et al.|Journal of Clinical Oncology|2020Cited by 1.2k
288eTiP A multicenter, open-label, first-in-human study of TYRA-430 in advanced hepatocellular carcinoma and other solid tumors with activating FGF/FGFR pathway aberrations (SURF431)Love Goyal, A. Zalutskaya, Raed Moh’d Taiseer Al-Rajabi et al.|Annals of Oncology|2025Cited by 0